If approved by DCGI, Covaxin will become only the second vaccine after Zydus Cadila’s ZyCoV-D to be granted permission for inoculating children in 2-18 age group.
Here is what the experts had to say on the development:
Dr Vinit Samdani, Pediatrician, Bhatia Hospital Mumbai said, “This is a major breakthrough in vaccinating children between 2 to 18 yrs. We are now seeing the light at the end of the tunnel we have been waiting for. Trials have been conducted on thousands of kids and there are two shots with a 20 days gap. Initially, there is going to be a close watch on any side effects and to report every 15 days for the first two months and then on monthly basis. We must wait for the launch officially. Initially, there will be few